InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Gannon, Steven. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 9 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €319k. History available since 12 May 2026. The latest transaction was disclosed on 11 August 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Steven Gannon is a declarant linked to Xenon Pharmaceuticals Inc., where he is listed as 4 - Director of Issuer. The 5 total filings are included in the recent sample, all dated 2026-06-05, with a modal transaction nature of 57 - Exercise of rights. The buy and sell amounts shown for these recent filings are EUR 0 and EUR 0.